#AIEye #Podcast 529: C3 AI (NYSE: $AI) Announces Strategic Alliance with Infor and Eros (NYSE: $ESGC) Now Collaborating with Google (NasdaqGS: $GOOG) Cloud for #AI #Tech
Global #AI in #Pharma to Reach $1.27 Billion in 2021
Point Roberts WA, Vancouver BC – March 8, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.
Listen to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2021/030821-AI-Eye.mp3
Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/03081AI-ESGC-GOOG.asp
Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence
Stocks discussed: (NYSE:AI) (NYSE:ESGC) (NasdaqGS:GOOG)
C3.ai, inc. (NYSE:AI) has announced a strategic alliance with business cloud software firm Infor to expand enterprise-class AI solutions across applicable industries to extend the latter’s native machine learning capabilities. According to the press release, Infor “plans to market, license, and deploy C3 AI prebuilt solutions,” and both companies intend to “collaborate on new integrated enterprise AI applications that can support specific industry needs.” C3 AI CEO Thomas M. Siebel said:
"Infor provides the enterprise resource planning, supply chain expertise, and data platform, while C3 AI brings the open, model-driven architecture of the C3 AI Suite that can reduce the time, complexity, and cost of developing and deploying enterprise-scale AI applications. This alliance is perfectly positioned to fast-track the delivery of scalable, industry-specific enterprise AI solutions. We believe the Infor and C3 AI alliance will provide a useful and robust complement for thousands of customers and prospects.”
Eros Now, the Indian OTT platform division of global entertainment company Eros STX Global Corporation (NYSE:ESGC), is collaborating with Google Cloud (NasdaqGS:GOOG) to “use its Artificial Intelligence (AI) technology for streaming the entire range of Eros Now movies and originals with automated subtitles.” Ali Hussein, CEO of Eros Now, commented:
"Eros has always been a pioneer in adopting technology to satiate the demands of audiences and build a deeper connection with them by offering unlimited entertainment. The innovative use of artificial intelligence and machine learning will give customized subtitled content for the global audience, allowing us to target a wider set of subscribers and drive engagement across Eros Now’ rich consumer offering."
Global AI in Pharma to Reach $1.27 Billion in 2021
Research published by ReportLinker finds that the global AI in Pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 with a compound annual growth rate (CAGR) of 39 percent. An excerpt from the report’s summary outlines the beneficial role played by AI in clinical trials:
The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand in the pharmaceutical market. To bring a new drug to the market takes on average 10–15 years, and half of this time is consumed during the clinical trial phases of the drug development cycle.
Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs.
Sam Mowers, Investorideas.com
Read and hear other editions of the AI Eye
For a list of artificial intelligence stocks on Investorideas.com visit here
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.
Visit the Podcast page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Technology stock investor ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment